Emergent BioSolutions awards $1.45M in additional retention bonuses to four top executives

Emergent BioSolutions Inc.

CFO Richard Lindahl receives $399,753; GC Jennifer Fox $380,250; EVP Quality Coleen Glessner $373,761; SVP Products Paul Williams $292,501.
Bonuses payable by Dec 31, 2024, subject to continued employment; acceleration possible upon transaction support agreement with debt holders.
Clawback: executives must repay bonuses if they voluntarily leave or are terminated for cause before retention period ends.
Retention period ends earlier of July 26, 2024 (initial bonuses), Dec 31, 2024 (additional), or 30 days after change of control or bankruptcy exit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.